Profit

Indian Pharma to prune R&D budget

PUBLISHED ON: November 5, 2008 | Duration: 1 min, 51 sec

  
loading..
The deepening global financial crisis is forcing a bitter pill down the throat of Indian drug makers with companies pruning their ambitious R&D plans. "If an industry's viewpoint is taken some changes will be there. The R&D spending will go down to 6-8 per cent from 10 per cent," said Dr CB Rao, deputy MD, Orchid Chemicals.
ALSO WATCH
Nifty Hits 11,600, Sensex Opens Above 38,400 For First Time

................................ Advertisement ................................

................................ Advertisement ................................